These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 416956)
1. Particulate tyrosinase of human malignant melanoma. Solubilization, purification following trypsin treatment, and characterization. Nishioka K Eur J Biochem; 1978 Apr; 85(1):137-46. PubMed ID: 416956 [No Abstract] [Full Text] [Related]
2. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma. Nishioka K FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193 [No Abstract] [Full Text] [Related]
3. Purification and isoelectric heterogeneity of chicken tyrosinase. Yamamoto H; Brumbaugh JA Biochim Biophys Acta; 1984 Aug; 800(3):282-90. PubMed ID: 6432056 [TBL] [Abstract][Full Text] [Related]
4. Mammalian tyrosinase: isozymic forms of the enzyme. Hearing VJ; Ekel TM; Montague PM Int J Biochem; 1981; 13(1):99-103. PubMed ID: 6781947 [No Abstract] [Full Text] [Related]
5. Tyrosinase of hamster melanoma: its purification and estimation by radioimmunoassay. Vachtenheim J; Duchon J; Matous B Comp Biochem Physiol B; 1987; 87(4):709-14. PubMed ID: 3117484 [TBL] [Abstract][Full Text] [Related]
10. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma. Garcia-Borron JC; Solano F; Iborra JL; Lozano JA Biochem J; 1985 May; 228(1):95-101. PubMed ID: 3924035 [TBL] [Abstract][Full Text] [Related]
11. Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion. Yurkow EJ; Laskin JD Arch Biochem Biophys; 1989 Nov; 275(1):122-9. PubMed ID: 2510599 [TBL] [Abstract][Full Text] [Related]
12. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma. Tomita Y; Moro S; Seiji M J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132 [No Abstract] [Full Text] [Related]
13. Demonstration of carbohydrate structures in malignant melanoma tyrosinase. Herrmann WP; Uhlenbruck G Klin Wochenschr; 1976 Jan; 54(2):95-6. PubMed ID: 814368 [TBL] [Abstract][Full Text] [Related]
14. Isolation of human tyrosinase from cultured melanoma cells. Wittbjer A; Dahlbäck B; Odh G; Rosengren AM; Rosengren E; Rorsman H Acta Derm Venereol; 1989; 69(2):125-31. PubMed ID: 2564229 [TBL] [Abstract][Full Text] [Related]
15. Tyrosinase activity in human ocular malignant melanoma. Hayasaka S; Nakazawa M; Ishiguro S; Mizuno K Graefes Arch Clin Exp Ophthalmol; 1986; 224(3):310-2. PubMed ID: 3086185 [TBL] [Abstract][Full Text] [Related]
16. Extracellular tyrosinase from Streptomyces sp. KY-453: purification and some enzymatic properties. Yoshimoto T; Yamamoto K; Tsuru D J Biochem; 1985 Jun; 97(6):1747-54. PubMed ID: 3928616 [TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of the tyrosinase of hamster melanoma with sodium diethyldithiocarbamate. Blagoeva P; Stoichev I Experientia; 1979 Oct; 35(10):1389-90. PubMed ID: 227716 [TBL] [Abstract][Full Text] [Related]
18. Purification of human skin tyrosinase and its protein inhibitor: properties of the enzyme and the mechanism of inhibition by protein. Vijayan E; Husain I; Ramaiah A; Madan NC Arch Biochem Biophys; 1982 Sep; 217(2):738-47. PubMed ID: 6814365 [No Abstract] [Full Text] [Related]
19. Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine. Jergil B; Lindbladh C; Rorsman H; Rosengren E Acta Derm Venereol; 1984; 64(2):155-7. PubMed ID: 6203305 [TBL] [Abstract][Full Text] [Related]
20. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase. Iwata K; Takeuchi T J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]